Asklepios BioPharmaceutical

Asklepios BioPharmaceutical focuses on the development of gene therapies for rare diseases and other serious conditions

Biotech & Life Sciences

Sector

Seed

Stage

B2B biopharmaceutical

Model

01Company Overview

Asklepios BioPharmaceutical focuses on the development of gene therapies for rare diseases and other serious conditions.

02Backed By1 investor

03Similar Companies

CB

Capsida Biotherapeutics

Biotech & Life Sciences

→

VT

U

BB

KB

04Startup DNA

8

signals

Sectors
Business Model
Technology